Found: 143
Select item for more details and to access through your institution.
In vivo assessment of glutamine anaplerosis into the TCA cycle in human pre-malignant and malignant clonal plasma cells.
- Published in:
- Cancer & Metabolism, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40170-020-00235-4
- By:
- Publication type:
- Article
Real-life sensitivity of flow cytometry minimal residual disease assessment for plasma cell neoplasms.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01081-z
- By:
- Publication type:
- Article
Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01039-1
- By:
- Publication type:
- Article
Muscle and fat composition in patients with newly diagnosed multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00934-3
- By:
- Publication type:
- Article
Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00957-w
- By:
- Publication type:
- Article
Long-term outcomes of allogeneic stem cell transplant in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00900-z
- By:
- Publication type:
- Article
An insidious cardiac sarcoma presenting with progressive neurologic dysfunction.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Metastatic meningioma presenting as cancer of unknown primary.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Impact of belantamab mafodotin‐induced ocular toxicity on outcomes of patients with advanced multiple myeloma.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 1, p. 95, doi. 10.1111/bjh.18298
- By:
- Publication type:
- Article
Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 2, p. 210, doi. 10.1111/bjh.17691
- By:
- Publication type:
- Article
Implications of detecting serum monoclonal protein by MASS‐fix following stem cell transplantation in multiple myeloma.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 380, doi. 10.1111/bjh.17195
- By:
- Publication type:
- Article
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 3, p. 394, doi. 10.1111/bjh.16168
- By:
- Publication type:
- Article
Ten‐year survivors in AL amyloidosis: characteristics and treatment pattern.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 5, p. 588, doi. 10.1111/bjh.16096
- By:
- Publication type:
- Article
Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 701, doi. 10.1111/bjh.15832
- By:
- Publication type:
- Article
Substratification of patients with newly diagnosed standard‐risk multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 2, p. 254, doi. 10.1111/bjh.15800
- By:
- Publication type:
- Article
Prevalence and survival of smouldering Waldenström macroglobulinaemia in the United States.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 6, p. 1014, doi. 10.1111/bjh.15201
- By:
- Publication type:
- Article
Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 1, p. 71, doi. 10.1111/bjh.15244
- By:
- Publication type:
- Article
Natural history of amyloidosis isolated to fat and bone marrow aspirate.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 170, doi. 10.1111/bjh.14205
- By:
- Publication type:
- Article
Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 98, doi. 10.1111/bjh.14826
- By:
- Publication type:
- Article
Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation.
- Published in:
- British Journal of Haematology, 2017, v. 178, n. 6, p. 888, doi. 10.1111/bjh.14830
- By:
- Publication type:
- Article
Quantification of clonal circulating plasma cells in relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 4, p. 500, doi. 10.1111/bjh.13067
- By:
- Publication type:
- Article
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1540, doi. 10.1002/ajh.27023
- By:
- Publication type:
- Article
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1277, doi. 10.1002/ajh.26990
- By:
- Publication type:
- Article
Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
- By:
- Publication type:
- Article
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survival.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 413, doi. 10.1002/ajh.26806
- By:
- Publication type:
- Article
Risk factors for severe infection and mortality In patients with COVID‐19 in patients with multiple myeloma and AL amyloidosis.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 1, p. 49, doi. 10.1002/ajh.26762
- By:
- Publication type:
- Article
Overexpression of the energy metabolism transcriptome within clonal plasma cells is associated with the pathogenesis and outcomes of patients with multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 895, doi. 10.1002/ajh.26577
- By:
- Publication type:
- Article
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcome.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 267, doi. 10.1002/ajh.26439
- By:
- Publication type:
- Article
Characteristics and risk factors for thrombosis in POEMS syndrome: A retrospective evaluation of 230 patients.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. 209, doi. 10.1002/ajh.26422
- By:
- Publication type:
- Article
Prognostic significance of acquired 1q22 gain in multiple myeloma.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. 52, doi. 10.1002/ajh.26391
- By:
- Publication type:
- Article
Venetoclax for the treatment of multiple myeloma: Outcomes outside of clinical trials.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 9, p. 1131, doi. 10.1002/ajh.26269
- By:
- Publication type:
- Article
Assessment of fixed‐duration therapies for treatment‐naïve Waldenström macroglobulinemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 945, doi. 10.1002/ajh.26210
- By:
- Publication type:
- Article
Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E157, doi. 10.1002/ajh.26125
- By:
- Publication type:
- Article
Comparison of the current renal staging, progression and response criteria to predict renal survival in AL amyloidosis using a Mayo cohort.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 4, p. 446, doi. 10.1002/ajh.26092
- By:
- Publication type:
- Article
Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone (VRd) as first‐line therapy in multiple myeloma.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 330, doi. 10.1002/ajh.26074
- By:
- Publication type:
- Article
Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association between race and survival of patients with non-small-cell lung cancer in the United States veterans affairs population.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Association Between Race and Survival of Patients With Non--Small-Cell Lung Cancer in the United States Veterans Affairs Population.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 2, p. 152, doi. 10.1016/j.cllc.2013.11.004
- By:
- Publication type:
- Article
Estimation of Kidney Function in Patients With Multiple Myeloma: Implications for Lenalidomide Dosing.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 1, p. 29, doi. 10.1177/10600280221087218
- By:
- Publication type:
- Article
Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Differences in the proteome within extracellular vesicles between premalignant and malignant plasma cell disorders.
- Published in:
- European Journal of Haematology, 2024, v. 113, n. 3, p. 351, doi. 10.1111/ejh.14246
- By:
- Publication type:
- Article
Failure of mobilization of hematopoietic stem cells associated with elevated serum levels of anti‐CD38 monoclonal antibody.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 2, p. 318, doi. 10.1111/ejh.14008
- By:
- Publication type:
- Article
Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 433, doi. 10.1111/ejh.13559
- By:
- Publication type:
- Article
Characterization and prognostic implication of delayed complete response in AL amyloidosis.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 354, doi. 10.1111/ejh.13554
- By:
- Publication type:
- Article
Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Palliative Chemotherapy: An Outdated Term for Life-Prolonging Systemic Therapies for Incurable Malignancies.
- Published in:
- Journal of Palliative Medicine, 2010, v. 13, n. 6, p. 641, doi. 10.1089/jpm.2009.0403
- By:
- Publication type:
- Article
Combination therapy incorporating Bcl‐2 inhibition with Venetoclax for the treatment of refractory primary plasma cell leukemia with t (11;14).
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel Therapies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 10, p. e329, doi. 10.1016/j.clml.2024.05.020
- By:
- Publication type:
- Article